Purinergic signaling in trauma and sepsis
Purinergic signaling in trauma and sepsis
批准号:
9379950
负责人:
George HASKO
金额:
$13.62万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2017-11-14
关键词:
AddressAdenosineAdenosine TriphosphateAdoptive TransferAnimalsBacteriaBindingBone MarrowBurn injuryCellsCessation of lifeClinicalClinical ResearchConnexinsCoupledCritical CareCritical IllnessDataDetectionExtracellular SpaceFunctional disorderG-substrateGPR105 receptorGTP-Binding ProteinsGoalsGrowthHMGB1 ProteinHeat shock proteinsHematopoieticHospitalsHost DefenseHyaluronanHypoxiaImmuneImmune responseImmune systemImmunityIn VitroInfectionInflammasomeInflammationInflammation ProcessInflammatoryInterleukin-1 betaKnock-outKnockout MiceLigandsLigationMediatingModelingMolecularMorbidity - disease rateMultiple Organ FailureMusMyelogenousOrganOrgan failureP2X-receptorPathway interactionsPatientsPatternPhagocytosisPharmacologyPropertyPuncture procedurePurinergic P1 ReceptorsPurinergic P2 ReceptorsPurinesReceptor ActivationRegulationResearchRoleSepsisShockSignal PathwaySignal TransductionSignaling MoleculeSurfaceSyndromeTarget PopulationsTestingTissuesTraumaUric Acidbaseclinically relevantextracellularfallsgain of functionimmune activationimmune functionimmunoregulationin vivokillingsloss of functionmacrophagemonocytemortalitynovelpathogenprotective effectreceptorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Sepsis is a clinical syndrome, which complicates severe infection. It remains the leading cause of morbidity
and mortality in critically ill patients. Current concepts suggest that organ failure and mortality in sepsis are
caused by inappropriate regulation of host defenses and the immune system. This manifests as an inability to
control bacterial growth and dissemination, and excessive inflammation, processes that are interrelated and
are due, in a large part, to macrophage dysfunction. Danger-associated molecular patterns (DAMP)s comprise
a diverse group of molecules that accumulate in the extracellular space in response to bacteria-mediated
tissue destruction, trauma, and burns, all of which are associated with sepsis. ATP is a major DAMP, which is
released from the intracellular into the extracellular space through connexins and pannexins during
inflammation, infection, shock, and sepsis. Extracellular ATP binds to and signals through P2 receptors to
modulate immune function. Our preliminary data with mice deficient in P2 receptors, as well as
pharmacological receptor and channel ligands establish that ATP release through connexin/pannexin channels
and subsequent P2 receptor activation are crucial for the control of mortality, bacterial killing and dissemination
and inflammation following cecal ligation and puncture, a clinically relevant model of polymicrobial sepsis.
Mechanistically, we show that ATP and one of the P2 receptors, the P2X4 receptor, protects against sepsis by
directly increasing the killing of bacteria by macrophages. Based on these data, we hypothesize that ATP
governs the host's response to sepsis by signaling through P2 receptors on macrophages. To address this
hypothesis, we will pursue the following Specific Aims: 1. Identify the mechanisms that support ATP release
during sepsis. 2. Dissect the mechanisms by which P2X4 receptor stimulation augments the killing of sepsis-
causing extracellular bacteria by macrophages. 3. Identify the monocyte/macrophage populations that are
targets of P2 receptor-mediated immune regulation in sepsis. The overarching goal here is to delineate the role
of P2 receptors in protecting against severe infection and to determine whether these receptors can be
specifically targeted to manage patients with sepsis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Recombinant E-NTPDase for shock
-
批准号:10757117
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:George HASKO
-
依托单位:
A2B receptor stimulation for sepsis
-
批准号:10545455
-
项目类别:
-
资助金额:$22.63万
-
财政年份:2022
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10478933
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10267891
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Neutrophil A2A receptors in sepsis
-
批准号:10657737
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2021
-
负责人:George HASKO
-
依托单位:
Soluble E-NTPDase for sepsis
-
批准号:9253962
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2017
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6910677
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:7429510
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6637820
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8069950
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:7655450
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6757946
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:6533462
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8504024
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8733173
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:8900797
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:9113958
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
Adenosine in trauma and sepsis
-
批准号:7370902
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2002
-
负责人:George HASKO
-
依托单位:
TREATMENT OF ARTHRITIS WITH AN ADENOSINE-3 AGONIST
-
批准号:2870252
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:George HASKO
-
依托单位:
NOVEL PARS INHIBITOR FOR THE THERAPY OF COLITIS
-
批准号:2825975
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:George HASKO
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: